AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $30,000 | -57.1% | 13,106 | -29.0% | 0.00% | -50.0% |
| Q2 2021 | $70,000 | +1300.0% | 18,451 | +1142.5% | 0.00% | – |
| Q1 2021 | $5,000 | -66.7% | 1,485 | -71.7% | 0.00% | -100.0% |
| Q4 2020 | $15,000 | +275.0% | 5,240 | +248.2% | 0.00% | – |
| Q3 2020 | $4,000 | -73.3% | 1,505 | -25.1% | 0.00% | -100.0% |
| Q1 2020 | $15,000 | +114.3% | 2,009 | +93.2% | 0.01% | +250.0% |
| Q4 2019 | $7,000 | +600.0% | 1,040 | +612.3% | 0.00% | – |
| Q3 2019 | $1,000 | -92.3% | 146 | -94.8% | 0.00% | -100.0% |
| Q2 2019 | $13,000 | +160.0% | 2,786 | +497.9% | 0.00% | +100.0% |
| Q2 2018 | $5,000 | -89.1% | 466 | -90.4% | 0.00% | -91.7% |
| Q1 2018 | $46,000 | -16.4% | 4,849 | +26.7% | 0.02% | -57.9% |
| Q2 2017 | $55,000 | – | 3,828 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |